Cargando…
Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19
Introduction Severe novel corona virus disease 2019 (COVID-19) causes dysregulation of the coagulation system with arterial and venous thromboembolism (VTE). We hypothesize that validated VTE risk scores would have prognostic ability in this population. Methods Retrospective observational cohort w...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219405/ https://www.ncbi.nlm.nih.gov/pubmed/34179684 http://dx.doi.org/10.1055/s-0041-1730293 |
_version_ | 1783710919404027904 |
---|---|
author | Paz Rios, Luis H. Minga, Iva Kwak, Esther Najib, Ayman Aller, Ashley Lees, Elizabeth Macrinici, Victor Rezaei Bookani, Kaveh Pursnani, Amit Caprini, Joseph Spyropoulos, Alex C. Tafur, Alfonso |
author_facet | Paz Rios, Luis H. Minga, Iva Kwak, Esther Najib, Ayman Aller, Ashley Lees, Elizabeth Macrinici, Victor Rezaei Bookani, Kaveh Pursnani, Amit Caprini, Joseph Spyropoulos, Alex C. Tafur, Alfonso |
author_sort | Paz Rios, Luis H. |
collection | PubMed |
description | Introduction Severe novel corona virus disease 2019 (COVID-19) causes dysregulation of the coagulation system with arterial and venous thromboembolism (VTE). We hypothesize that validated VTE risk scores would have prognostic ability in this population. Methods Retrospective observational cohort with severe COVID-19 performed in NorthShore University Health System. Patients were >18 years of age and met criteria for inpatient or intensive care unit (ICU) care. The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) and Caprini scores were calculated and patients were stratified. Results This study includes 184 patients, mostly men (63.6%), Caucasian (54.3%), 63 years old (interquartile range [IQR]: 24–101), and 57.1% of them required ICU care. Twenty-seven (14.7%) thrombotic events occurred: 12 (6.5%) cases of disseminated intravascular coagulation (DIC), 9 (4.9%) of pulmonary embolism, 5 (2.7%) of deep vein thrombosis, and 1 (0.5%) stroke. Among them, 86 patients (46.7%) died, 95 (51.6%) were discharged, and 3 (1.6%) were still hospitalized. “Moderate risk for VTE” and “High risk for VTE” by IMPROVE score had significant mortality association: (hazard ratio [HR]: 5.68; 95% confidence interval [CI]: 2.93–11.03; p < 0.001) and (HR = 6.22; 95% CI: 3.04–12.71; p < 0.001), respectively, with 87% sensitivity and 63% specificity (area under the curve [AUC] = 0.752, p < 0.001). “High Risk for VTE” by Caprini score had significant mortality association (HR = 17.6; 95% CI: 5.56–55.96; p < 0.001) with 96% sensitivity and 55% specificity (AUC = 0.843, p < 0.001). Both scores were associated with thrombotic events when classified as “High risk for VTE” by IMPROVE (HR = 6.50; 95% CI: 2.72–15.53; p < 0.001) and Caprini scores (HR = 11.507; 95% CI: 2.697–49.104; p = 0.001). Conclusion The IMPROVE and Caprini risk scores were independent predictors of mortality and thrombotic events in severe COVID-19. With larger validation, this can be useful prognostic information. |
format | Online Article Text |
id | pubmed-8219405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-82194052021-06-24 Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 Paz Rios, Luis H. Minga, Iva Kwak, Esther Najib, Ayman Aller, Ashley Lees, Elizabeth Macrinici, Victor Rezaei Bookani, Kaveh Pursnani, Amit Caprini, Joseph Spyropoulos, Alex C. Tafur, Alfonso TH Open Introduction Severe novel corona virus disease 2019 (COVID-19) causes dysregulation of the coagulation system with arterial and venous thromboembolism (VTE). We hypothesize that validated VTE risk scores would have prognostic ability in this population. Methods Retrospective observational cohort with severe COVID-19 performed in NorthShore University Health System. Patients were >18 years of age and met criteria for inpatient or intensive care unit (ICU) care. The International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) and Caprini scores were calculated and patients were stratified. Results This study includes 184 patients, mostly men (63.6%), Caucasian (54.3%), 63 years old (interquartile range [IQR]: 24–101), and 57.1% of them required ICU care. Twenty-seven (14.7%) thrombotic events occurred: 12 (6.5%) cases of disseminated intravascular coagulation (DIC), 9 (4.9%) of pulmonary embolism, 5 (2.7%) of deep vein thrombosis, and 1 (0.5%) stroke. Among them, 86 patients (46.7%) died, 95 (51.6%) were discharged, and 3 (1.6%) were still hospitalized. “Moderate risk for VTE” and “High risk for VTE” by IMPROVE score had significant mortality association: (hazard ratio [HR]: 5.68; 95% confidence interval [CI]: 2.93–11.03; p < 0.001) and (HR = 6.22; 95% CI: 3.04–12.71; p < 0.001), respectively, with 87% sensitivity and 63% specificity (area under the curve [AUC] = 0.752, p < 0.001). “High Risk for VTE” by Caprini score had significant mortality association (HR = 17.6; 95% CI: 5.56–55.96; p < 0.001) with 96% sensitivity and 55% specificity (AUC = 0.843, p < 0.001). Both scores were associated with thrombotic events when classified as “High risk for VTE” by IMPROVE (HR = 6.50; 95% CI: 2.72–15.53; p < 0.001) and Caprini scores (HR = 11.507; 95% CI: 2.697–49.104; p = 0.001). Conclusion The IMPROVE and Caprini risk scores were independent predictors of mortality and thrombotic events in severe COVID-19. With larger validation, this can be useful prognostic information. Georg Thieme Verlag KG 2021-06-22 /pmc/articles/PMC8219405/ /pubmed/34179684 http://dx.doi.org/10.1055/s-0041-1730293 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Paz Rios, Luis H. Minga, Iva Kwak, Esther Najib, Ayman Aller, Ashley Lees, Elizabeth Macrinici, Victor Rezaei Bookani, Kaveh Pursnani, Amit Caprini, Joseph Spyropoulos, Alex C. Tafur, Alfonso Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 |
title | Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 |
title_full | Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 |
title_fullStr | Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 |
title_full_unstemmed | Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 |
title_short | Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19 |
title_sort | prognostic value of venous thromboembolism risk assessment models in patients with severe covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219405/ https://www.ncbi.nlm.nih.gov/pubmed/34179684 http://dx.doi.org/10.1055/s-0041-1730293 |
work_keys_str_mv | AT pazriosluish prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT mingaiva prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT kwakesther prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT najibayman prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT allerashley prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT leeselizabeth prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT macrinicivictor prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT rezaeibookanikaveh prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT pursnaniamit prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT caprinijoseph prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT spyropoulosalexc prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 AT tafuralfonso prognosticvalueofvenousthromboembolismriskassessmentmodelsinpatientswithseverecovid19 |